owkin.comHealthcare / BioTech & PharmaFounded: 2016Funding to Date: $279.77MM
Owkin is an AI biotech company using federated learning to connect biopharma companies and medical partners. Owkin's technology unlocks insights from siloed datasets that allow for the development of precise medical approaches to the treatment of disease. Owkin was founded in 2016 by Dr. Thomas Clozel and Dr. Gilles Wainrib and is headquartered in New York, NY.
Funding Date | Share Class | Amount Raised | Price per Share | Post-Money Valuation | Key Investors | |
---|---|---|---|---|---|---|
06/08/2022 | Series B-1 | $50MM | $xx.xx | $1.46B | Bristol Myers Squibb | |
Price per Share
$xx.xx
Shares Outstanding
1,094,169
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Bristol Myers Squibb
|
||||||
11/18/2021 | Series B | $155.04MM | $xx.xx | $1.29B | Sanofi | |
Price per Share
$xx.xx
Shares Outstanding
3,602,182
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Sanofi
|
||||||
05/07/2020 | Series A-3 | $43.55MM | $xx.xx | $252.21MM | Bpifrance Large Venture, Cathay Innovation, MACSF, GV, F-Prime Capital, Eight Roads Ventures | |
Price per Share
$xx.xx
Shares Outstanding
4,860,488
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Bpifrance Large Venture, Cathay Innovation, MACSF, GV, F-Prime Capital, Eight Roads Ventures
|
||||||
03/07/2019 | Series A-2 | $13.04MM | $xx.xx | $113.97MM | F-Prime Capital, Eight Roads Ventures, GV, Cathay Innovation, NJF Capital | |
Price per Share
$xx.xx
Shares Outstanding
2,502,208
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
F-Prime Capital, Eight Roads Ventures, GV, Cathay Innovation, NJF Capital
|
||||||
05/24/2018 | Series A | $16.02MM | $xx.xx | $51.43MM | GV, Otium Venture, Cathay Innovation, Plug and Play Ventures, NJF Capital | |
Price per Share
$xx.xx
Shares Outstanding
5,936,265
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
GV, Otium Venture, Cathay Innovation, Plug and Play Ventures, NJF Capital
|
||||||
05/01/2017 | Series Seed | $2.12MM | $xx.xx | $7.06MM | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
3,589,861
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Undisclosed Investors
|